Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 9, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-03
DOI
10.1038/s41408-019-0261-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAR-T Cell Therapy in B cell Non-Hodgkin Lymphomas
- (2019) Adam Levin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
- (2019) Narendranath Epperla et al. Journal of Hematology & Oncology
- Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation
- (2019) Abraham S. Kanate et al. JAMA Oncology
- Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease: Results from the Phase 2 REACH1 Trial
- (2019) Madan Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation
- (2018) Narendranath Epperla et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
- (2018) Norbert Schmitz et al. BLOOD
- The impact of advanced patient age on mortality after allogeneic hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma: A retrospective study by the EBMT Lymphoma Working Party
- (2018) Charalampia Kyriakou et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improved survival after acute graft- versus -host disease diagnosis in the modern era
- (2017) Hanna J. Khoury et al. HAEMATOLOGICA
- Improved survival after acute graft- versus -host disease diagnosis in the modern era
- (2017) Hanna J. Khoury et al. HAEMATOLOGICA
- Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients
- (2016) Timothy S. Fenske et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
- (2016) Timothy S. Fenske et al. BRITISH JOURNAL OF HAEMATOLOGY
- Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis
- (2016) Nilanjan Ghosh et al. JOURNAL OF CLINICAL ONCOLOGY
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors
- (2015) Evgeny Klyuchnikov et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
- (2015) A. S. Kanate et al. BLOOD
- Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas
- (2015) E. A. Chong et al. CLINICAL CANCER RESEARCH
- Autologous hematopoietic cell transplantation: An update for clinicians
- (2014) Mehdi Hamadani ANNALS OF MEDICINE
- Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival
- (2014) Brian L. McClune et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
- (2014) S. M. Horwitz et al. BLOOD
- Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma
- (2014) Michelle Furtado et al. BRITISH JOURNAL OF HAEMATOLOGY
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
- (2013) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
- (2013) Timothy S. Fenske et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
- (2011) Mohamed L. Sorror et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models
- (2010) Xu Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Defining the Intensity of Conditioning Regimens: Working Definitions
- (2009) Andrea Bacigalupo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started